Virtual Event | December 19, 2022

Strategies for Development of Next-Gen AAVs

Source: Cytiva

In this video, Douglas Sanders, Ph.D., VP Head of Translational Medicine at AVROBIO details why the field is now recognizing that natural naturally occurring AAVs have both strengths and drawbacks. Sanders explains the strengths and drawbacks and why now is an exciting and important time in AAV biology.

access the Virtual Event!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)

Cytiva